Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.
about
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patientsNonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetesRole of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectivesCleavage of oxidized guanine nucleotide and ADP sugar by human NUDT5 proteinNitric oxide synthases: regulation and functionA hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular diseaseEffect of lower limb exercise on forearm vascular function: contribution of nitric oxide.Nitric oxide in the pathogenesis of vascular disease.Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitusModification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus.Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats.Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat.The roles of glycated albumin as intermediate glycation index and pathogenic protein.Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal.Glycation does not modify bovine serum albumin (BSA)-induced reduction of rat aortic relaxation: the response to glycated and nonglycated BSA is lost in metabolic syndrome.Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition.Exercise therapy in type 2 diabetes.Kidney aging--inevitable or preventable?Diabetes, aging, and their tissue complications.Postural variation of pulmonary diffusing capacity as a marker of lung microangiopathy in Indian patients with type 2 diabetes mellitusDo Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.Nitric oxide-based possibilities for pharmacotherapy.Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications.Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome.Advanced glycation end-products and atherosclerosis.Structural modifications of proteins during aging.6. Diabetic NephropathyTetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells.Serum N-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patients.Soluble receptor for advanced glycation end products in male infertility.Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging
P2860
Q24561776-FD79C422-2D84-452F-9145-B78B9A66CE2BQ24627259-1B29EA41-E0D5-42A6-A16C-032868E382ADQ26824706-7617AD94-F498-465E-832C-9F70ACEF8619Q28115291-7F4A485A-0F6F-4630-8286-62C9FA8F80F6Q28247092-54BFD89F-4355-4A19-B759-964CCA1E9AE6Q28361892-5EADE7C8-A208-4B5E-9AA0-1DF080A4A027Q30843209-AAA80E6D-B018-4F67-BE10-30F742ACE21EQ33843539-86509CA0-BBD9-438C-8754-4E5A18A5CC46Q35216447-6C19B9E0-067C-47C9-B327-82C02FA09C8CQ35610369-FA60C99D-8321-4DE0-9898-1AE08C6EED12Q35788419-A6E5B825-2F0C-4DA0-BD51-3684582F9002Q35830289-D82441BC-F178-4C11-B07E-0CE10640634DQ35833696-91F2075E-8EA6-45AF-91AD-BB1D40BC1A16Q35874287-E0D2DC30-5834-4AFA-8D03-F6F45D97B7FDQ35874337-B8F364D7-53F5-45DE-AC28-0D78554DB205Q35911117-9EC526DA-3E59-4D6D-B527-1B5F2BC51100Q36574142-A8482491-8278-4E29-93E8-6CEEE2E5A1EDQ36666934-6B2992FD-76C7-43CD-AB08-28BCD033733BQ36724696-1FC824FB-4D2A-44CD-807D-2306E3447733Q36877791-5122DD77-0FB7-435D-9AC5-02586170A156Q37412024-AF1209DE-2A37-4451-AE54-50C027F1010FQ37913979-9C8E80AD-D81B-4879-89F3-7D2EFAC6701CQ38208801-3602E2AA-D2EB-4FDB-BCC9-C20E954CCE2FQ39005676-A0191096-D43E-47A2-92B0-B13D630F1885Q39158946-75939818-DA88-4813-93E9-5F32EF3C303CQ40345085-29A810E9-12DF-4B6A-9D06-96A7ECD620EFQ40405202-F7AB8B58-D42F-4413-BD8B-A7025A31D4A4Q40547285-B84143F2-80AD-4FB8-8F31-6C7F61AA064DQ41091130-E0EE1718-3269-4B3D-B41B-B6711282768FQ41250355-84B728E9-A12F-4120-AFE8-D718124AD247Q41524554-0EBDCD7C-18FD-4906-B1D8-07C62C1025B3Q42378585-15051531-739E-4B51-B790-4AFAFDC30D07Q43635194-9C9A587A-994C-4A7C-B365-C8A767E83FD7Q44386543-D590FAC4-57EC-4E19-B62B-2AE03959D621Q55180476-7290A507-9EF1-487B-892D-D721A77ABA61Q57051319-FED0BE6A-D900-4EAD-BE4B-82E751F96502
P2860
Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Advanced glycosylation endprod ...... ications of diabetes mellitus.
@ast
Advanced glycosylation endprod ...... ications of diabetes mellitus.
@en
type
label
Advanced glycosylation endprod ...... ications of diabetes mellitus.
@ast
Advanced glycosylation endprod ...... ications of diabetes mellitus.
@en
prefLabel
Advanced glycosylation endprod ...... ications of diabetes mellitus.
@ast
Advanced glycosylation endprod ...... ications of diabetes mellitus.
@en
P2093
P2860
P356
P1476
Advanced glycosylation endprod ...... ications of diabetes mellitus.
@en
P2093
P2860
P304
P356
10.1172/JCI115928
P407
P577
1992-09-01T00:00:00Z